Muge Kuyumcu-Martinez, PhD, a professor in the Department of Molecular Physiology and Biological Physics at UVA, recently presented her groundbreaking research on Hypoplastic Left Heart Syndrome (HLHS) at the American Heart Association Basic Cardiovascular Sciences Conference. Her findings, highlighting the mechanisms of how mutations in an RNA binding protein RBFOX2 lead to this congenital heart defect, received widespread acclaim. Dr. Kuyumcu-Martinez ‘s talk, “RBFOX2-RNA networks in heart development and Hypoplastic left Heart Syndrome,” revealed new mechanisms that cause HLHS.
In an exclusive interview at the American Heart Association Conference, Dr. Kuyumcu-Martinez highlighted the potential of her findings to advance the understanding of this devastating disease that affects infants. “Our research opens new avenues for RNA based therapies for heart disease in the future,” she stated.
Dr. Kuyumcu-Martinez’s research advances our understanding of this complex congenital heart disease and offers hope for improving the lives of adult patients in the future.
Learn more about Dr. Kuyumcu-Martinez’s research or contact her at pnc3uj@virginia.edu.
Filed Under: Research